Document › Details
AB Sciex. (5/21/12). "Press Release: AB Sciex Launches Next-generation TripleTOF 5600 System". Framingham, MA.
|Organisation||AB Sciex LLC|
|Organisation 2||Buck Institute for Age Research|
|Product||AB Sciex TripleTOF™ 5600+ System|
|Product 2||SWATH™ Acquisition|
|Person||Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle)|
|Person 2||Hicks, Dave (Danaher 201004 VP + General Manager Pharmaceuticals + Proteomics at AB SCIEX)|
New system in TripleTOF™ family delivers advanced features, including SWATH™ Acquisition, SelexION™ compatibility and software that is capable of supporting 21 CFR Part 11 compliance
AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the second generation of the TripleTOF™ 5600 System. The new TripleTOF™ 5600+ System delivers new innovation for biomolecule research with MS/MSALL with SWATH™ Acquisition and supports a higher level of selectivity when coupled with SelexION™ Technology. The new system also comes with software that is capable of supporting 21 CFR Part 11 compliance, making TripleTOF™ technology more accessible for regulated labs in the pharmaceutical industry. The TripleTOF 5600+ is on display at this week's American Society of Mass Spectrometry (ASMS) conference in Vancouver.
The new TripleTOFTM 5600+ system represents an advancement in accurate mass technology that combines high resolution with high sensitivity and high speed. This new system builds on the proven innovation of the TripleTOF™ 5600, which was launched at ASMS in 2010. The new TripleTOF™ 5600+ system is now the industry's fastest, high sensitivity and high-resolution mass spectrometer for simultaneous high-performance qualitative and quantitative analysis. A built-in capability to support SelexION™ Technology also adds versatility and breakthrough levels of selectivity.
By incorporating support for MS/MSALL with SWATH™ Acquisition on the TripleTOF™ 5600+ platform, researchers will be able to obtain more information about proteins, peptides and other biomolecules from a sample than ever before. SWATH™ Acquisition is a groundbreaking mass spectrometry-based technique that quantifies nearly all peptides and proteins in a sample from a single analysis. The TripleTOF™ 5600+ is the only platform in the industry that has the speed, sensitivity and dynamic range to enable SWATH™ Acquisition, which was developed through a collaboration with Ruedi Aebersold, Ph.D., a leading proteomics researcher who is based at ETH Zurich. The scientific community has already responded with positive feedback.
"The combination of the AB SCIEX TripleTOF™ 5600+ system and the recent development of SWATH acquisition has completely changed how I think about designing and implementing quantitative proteomics studies," said Bradford W. Gibson, Ph.D., Professor & Director of Chemistry and Mass Spectrometry, Buck Institute for Research on Aging. "The high resolution and fast scanning capabilities of the TripleTOF have made it possible for the first time to acquire MS and MS/MS ion intensity data on essentially all peptides in a single run that can be mined both immediately and retrospectively. This is truly a revolutionary combination of instrumentation technologies and software innovation."
AB SCIEX is also extending the utility of TripleTOF™ technology for use in pharmaceutical laboratories, addressing a need for compliance to 21 CFR Part 11 for electronic records and signatures. With software that is capable of supporting 21 CFR Part 11 compliance, the new TripleTOF solution opens up new possibilities for drug discovery labs to meet this regulatory requirement.
"The launch of the TripleTOF 5600+ System is exactly two years after the first TripleTOF instrument broke new ground in the mass spectrometry industry and changed the way scientists approach analyses of drugs, contaminants and proteins," said Dave Hicks, Vice President of the Pharma & Academic Business at AB SCIEX. "Now, we are continuing the evolution of the TripleTOF platform with new functionality that directly addresses feedback from customers who want to push the limits in their quantitative and qualitative analyses."
Compatibility with SelexION™ Technology is another new feature of the TripleTOFTM 5600+ system developed in response to customer feedback garnered ever since AB SCIEX launched it at ASMS in 2011. SelexION™ Technology delivers a new dimension of selectivity by adding differential ion mobility to conventional mass spectrometry for both quantitative and qualitative analysis. It significantly improves selectivity and performance for any application requiring the separation of isobaric species, isolation of challenging co-eluting contaminants and elimination of high background noise. This advancement reduces sample preparation requirements and improves overall data quality.
About AB SCIEX
AB SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company's global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 25 years of proven innovation, AB SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please go to www.absciex.com. Follow AB SCIEX on Twitter @ABSCIEX and on Facebook.
AB Sciex Instruments Are For Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.
Record changed: 2016-03-19
More documents for Danaher (Group)
-  Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf....
-  Bayer AG. (12/21/16). "Press Release: Bayer Develops Companion Diagnostic Test for Cancer Patients Together with Leica Biosystems [Not intended for U.S. and UK Media]". Leverkusen....
-  Danaher Corporation. (12/1/16). "Press Release: Danaher Announces Leadership Appointment". Washington, DC....
-  Phenomenex, Inc.. (11/30/16). "Press Release: New Clarity Columns Refine RP and IEX Chromatographic Analysis of Synthetic Oligonucleotides". Torrance, CA....
-  Pressure BioSciences, Inc.. (11/16/16). "Press Release: Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update". South Easton, MA....
-  AB Sciex (d/b/a Sciex). (11/10/16). "Press Release: Sciex Supports Vital Cancer Prevention Research through Partnership with World Cancer Research Fund". Framingham, MA....
-  Danaher Corporation. (11/4/16). "Press Release: Danaher Completes Acquisition of Cepheid". Washington, DC....
-  Danaher Corporation. (10/31/16). "Press Release: Danaher to Present at Baird Industrial Conference". Washington, DC....
-  AB Sciex (d/b/a Sciex). (10/27/16). "Press Release: Scientists Eradicate Leukemic Stem Cells by Targeting Cell Survival Proteins. Sciex Mass Spectrometry-based Solutions Lead to Leukemia Breakthroughs". Framingham, MA....
-  Phenomenex, Inc.. (10/25/16). "Press Release: Phenomenex Adds Polar Mixed-Mode Selectivities to Luna LC Column Line". Torrance, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]